Neil Peterson - Aug 22, 2023 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Stock symbol
MMSI
Transactions as of
Aug 22, 2023
Transactions value $
-$317,688
Form type
4
Date filed
8/23/2023, 11:32 AM
Previous filing
Mar 20, 2023
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock Options Exercise $226K +8K $28.20 8K Aug 22, 2023 Direct
transaction MMSI Common Stock Sale -$543K -8K -100% $67.91 0 Aug 22, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -8K -100% $0.00* 0 Aug 22, 2023 Common Stock 8K $28.20 Direct F2
holding MMSI Non-qualified stock options (right to buy) 15K Aug 22, 2023 Common Stock 15K $44.80 Direct F3
holding MMSI Non-qualified stock options (right to buy) 20K Aug 22, 2023 Common Stock 20K $54.40 Direct F4
holding MMSI Non-qualified stock options (right to buy) 25K Aug 22, 2023 Common Stock 25K $68.33 Direct F5
holding MMSI Non-qualified stock options (right to buy) 13.6K Aug 22, 2023 Common Stock 13.6K $70.58 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.79 to $68.05 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 Becomes exercisable in equal annual installments of 20% commencing 4/14/2018.
F3 Becomes exercisable in equal annual installments of 20% commencing 3/2/2019.
F4 Becomes exercisable in equal annual installments of 20% commencing 4/25/2020.
F5 Becomes exercisable in equal annual installments of 25% commencing 8/19/2022.
F6 Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.